Glycopyrronium · Medicine question

What action does the product information recommend if symptoms of acute narrow-angle glaucoma develop during treatment with Seebri Breezhaler (glycopyrronium)?

Name: What action does the product information recommend if symptoms of acute narrow-angle glaucoma develop during treatment with Seebri Breezhaler (glycopyrronium)?
Published: 2026-11-08T14:16:25.849Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

If signs or symptoms of acute narrow-angle glaucoma develop, patients should stop using Seebri Breezhaler (glycopyrronium) and contact their doctor immediately.

Sources for this answer

Seebri Breezhaler Inhalation Powder, Hard Capsules 44mcgNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 12Document updated 15 July 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about Glycopyrronium